Publications by authors named "Stefania Meini"

Claim this Profile
B
Booster immunization with a fractional dose of Prevnar 13 affects cell-mediated immune response but not humoral immunity in CD-1 mice.
Rose-Marie Catalioto, Claudio Valenti, Francesca Bellucci, Cecilia Cialdai, Maria Altamura, Stefania Meini

Heliyon· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position 9.
Francesco Merlino, Diego Brancaccio, Ali M Yousif, Linda Piras, Pietro Campiglia, Stefania Meini

ChemMedChem· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation.
Erika Terzuoli, Stefania Meini, Paola Cucchi, Claudio Catalani, Cecilia Cialdai

PLoS One· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor.
Alfonso Carotenuto, Luigia Auriemma, Francesco Merlino, Ali Munaim Yousif, Daniela Marasco, Stefania Meini

J Med Chem· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonist profile of ibodutant at the tachykinin NK(2) receptor in guinea pig isolated bronchi.
Paolo Santicioli, Stefania Meini, Sandro Giuliani, Alessandro Lecci, Carlo Alberto Maggi

Eur J Pharmacol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide.
Alfonso Carotenuto, Luigia Auriemma, Francesco Merlino, Antonio Limatola, Pietro Campiglia, Stefania Meini

J Pept Sci· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of ibodutant at NK(2) receptor in human colon.
Paolo Santicioli, Stefania Meini, Sandro Giuliani, Claudio Catalani, Paolo Bechi

Eur J Pharmacol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of novel sulfonamide-containing bradykinin hB(2) receptor antagonists. Synthesis and structure-relationships of α,α-tetrahydropyranylglycine.
Christopher I Fincham, Alessandro Bressan, Piero D'Andrea, Alessandro Ettorre, Sandro Giuliani, Stefania Meini

Bioorg Med Chem· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioligand binding characterization of the bradykinin B(2) receptor in the rabbit and pig ileal smooth muscle.
Stefania Meini, Paola Cucchi, Claudio Catalani, Francesca Bellucci, Paolo Santicioli

Eur J Pharmacol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of 6-methyl-benzo[b]thiophene-2-carboxylic acid (1-[(S)-1-benzyl-4-[4-(tetrahydropyran-4-ylmethyl)piperazin-1-yl]butylcarbamoyl]cyclopentyl)amide, potent antagonist of the neurokinin-2 receptor.
Daniela Fattori, Marina Porcelloni, Piero D'Andrea, Rose-Marie Catalioto, Alessandro Ettorre, Stefania Meini

J Med Chem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tachykinin receptor assays.
Stefania Meini, Carlo Alberto Maggi

Curr Protoc Pharmacol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation on C- and N-terminal moieties of a series of potent and selective linear tachykinin NK(2) receptor antagonists.
Martina Gensini, Maria Altamura, Tula Dimoulas, Valentina Fedi, Danilo Giannotti, Stefania Meini

ChemMedChem· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of the bradykinin B2 receptor antagonist MEN16132 in rat in vitro bioassays.
Stefania Meini, Paola Cucchi, Claudio Catalani, Francesca Bellucci, Sandro Giuliani

Eur J Pharmacol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.
Paolo Grieco, Alfonso Carotenuto, Pietro Campiglia, Isabel Gomez-Monterrey, Luigia Auriemma, Stefania Meini

J Med Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifaceted approach to determine the antagonist molecular mechanism and interaction of ibodutant ([1-(2-phenyl-1R-[[1-(tetrahydropyran-4-ylmethyl)-piperidin-4-ylmethyl]-carbamoyl]-ethylcarbamoyl)-cyclopentyl]-amide) at the human tachykinin NK2 receptor.
Stefania Meini, Francesca Bellucci, Claudio Catalani, Paola Cucchi, Alessandro Giolitti

J Pharmacol Exp Ther· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cinnamic acids and mono-substituted benzoic acids as useful capping groups for the preparation of hNK2 receptor antagonists.
Marina Porcelloni, Piero D'Andrea, Maria Altamura, Rose-Marie Catalioto, Sandro Giuliani, Stefania Meini

Bioorg Med Chem Lett· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
alpha,alpha-Cyclopentaneglycine dipeptides capped with biaryls as tachykinin NK(2) receptor antagonists.
Marina Porcelloni, Piero D'Andrea, Cristina Rossi, Alessandro Sisto, Alessandro Ettorre, Stefania Meini

ChemMedChem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a new series of potent and selective linear tachykinin NK2 receptor antagonists.
Valentina Fedi, Maria Altamura, Rose-Marie Catalioto, Danilo Giannotti, Alessandro Giolitti, Stefania Meini

J Med Chem· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 2. Synthesis and structure-activity relationships of alpha,alpha-cycloalkylglycine sulfonamides.
Daniela Fattori, Cristina Rossi, Christopher I Fincham, Valerio Caciagli, Fernando Catrambone, Stefania Meini

J Med Chem· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cecilia Cialdai, Manuela Tramontana, Riccardo Patacchini, Alessandro Lecci, Claudio Catalani, Stefania Meini

Eur J Pharmacol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 1. Synthesis and SAR of alpha,alpha-dimethylglycine sulfonamides.
Daniela Fattori, Cristina Rossi, Christopher I Fincham, Marco Berettoni, Federico Calvani, Stefania Meini

J Med Chem· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bradykinin antagonists modified with dipeptide mimetic beta-turn inducers.
Maria C Alcaro, Valerio Vinci, Anna M D'Ursi, Mario Scrima, Mario Chelli, Stefania Meini

Bioorg Med Chem Lett· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
Paola Cucchi, Stefania Meini, Alessandro Bressan, Claudio Catalani, Francesca Bellucci

Eur J Pharmacol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
Claudio Valenti, Cecilia Cialdai, Sandro Giuliani, Alessandro Lecci, Manuela Tramontana, Stefania Meini

J Pharmacol Exp Ther· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.
Stefania Meini, Claudio Catalani, Francesca Bellucci, Paola Cucchi, Sandro Giuliani

Eur J Pharmacol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis